SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).


Journal

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 22 10 2018
accepted: 29 10 2018
pubmed: 18 11 2018
medline: 16 5 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper molecular knowledge; so, more options can be offered to patients with driver mutations. Groups with specific treatments account for around 25% and demonstrate significant increases in overall survival, and in some subgroups, it is important to evaluate each treatment alternative in accordance with scientific evidence, and even more so with immunotherapy. New treatments similarly mean that we must reconsider what should be done in oligometastatic disease where local treatment attains greater value.

Identifiants

pubmed: 30446985
doi: 10.1007/s12094-018-1978-1
pii: 10.1007/s12094-018-1978-1
pmc: PMC6339680
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-17

Références

Pract Radiat Oncol. 2017 Sep - Oct;7(5):295-301
pubmed: 28596092
J Clin Oncol. 2005 Jan 1;23(1):190-6
pubmed: 15625373
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
PLoS One. 2012;7(5):e37229
pubmed: 22615946
J Clin Oncol. 2018 Aug 1;36(22):2244-2250
pubmed: 29864379
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Cancer Discov. 2017 Apr;7(4):400-409
pubmed: 28183697
J Clin Oncol. 2018 Mar 20;36(9):911-919
pubmed: 29401004
J Clin Oncol. 1998 Jul;16(7):2459-65
pubmed: 9667264
J Thorac Oncol. 2012 Dec;7(12):1807-1814
pubmed: 23154552
J Clin Oncol. 2007 Jan 20;25(3):313-8
pubmed: 17235046
Ann Thorac Surg. 2016 Mar;101(3):1230-7
pubmed: 27124326
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
N Engl J Med. 2006 Dec 14;355(24):2542-50
pubmed: 17167137
J Clin Oncol. 2007 Nov 20;25(33):5233-9
pubmed: 18024869
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
J Clin Oncol. 2017 Dec 20;35(36):4027-4034
pubmed: 28968167
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
Lancet Oncol. 2017 Nov;18(11):1454-1466
pubmed: 28958502
Ann Oncol. 2004 Mar;15(3):419-26
pubmed: 14998843
J Clin Oncol. 2005 May 1;23(13):2926-36
pubmed: 15728229
Cochrane Database Syst Rev. 2015 Mar 02;(3):CD011430
pubmed: 25730344
Lancet. 2010 Apr 10;375(9722):1267-77
pubmed: 20338627
Ann Intern Med. 1996 Nov 1;125(9):723-9
pubmed: 8929005
J Clin Oncol. 2018 Aug 28;:JCO2018783118
pubmed: 30153097
Ann Oncol. 2018 Jun 1;29(6):1409-1416
pubmed: 29668860
J Clin Oncol. 2000 Jan;18(1):122-30
pubmed: 10623702
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
Clin Transl Oncol. 2015 Feb;17(2):103-12
pubmed: 25351175
J Clin Oncol. 2013 Aug 10;31(23):2895-902
pubmed: 23835707
N Engl J Med. 2002 Jan 10;346(2):92-8
pubmed: 11784875
Lancet. 2009 Aug 1;374(9687):379-86
pubmed: 19632716
J Clin Oncol. 2013 Aug 10;31(23):2849-53
pubmed: 23775961
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Ann Thorac Surg. 2006 Aug;82(2):408-15; discussion 415-6
pubmed: 16863738
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27
pubmed: 27664245
Lancet Oncol. 2015 Jul;16(7):830-8
pubmed: 26051236
Lancet. 2017 Jan 21;389(10066):255-265
pubmed: 27979383
J Natl Cancer Inst. 2003 Mar 5;95(5):362-72
pubmed: 12618501
J Natl Cancer Inst. 2007 Jun 6;99(11):847-57
pubmed: 17551145
N Engl J Med. 2014 Dec 4;371(23):2167-77
pubmed: 25470694
J Clin Oncol. 2017 Aug 1;35(22):2490-2498
pubmed: 28475456
J Geriatr Oncol. 2018 Jul;9(4):337-345
pubmed: 29248435
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
N Engl J Med. 2018 Mar 1;378(9):869-870
pubmed: 29490170
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Lancet. 2017 Mar 4;389(10072):917-929
pubmed: 28126333
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Lancet. 2014 May 3;383(9928):1561-71
pubmed: 24576776
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
N Engl J Med. 2018 Nov 22;379(21):2027-2039
pubmed: 30280657
Lancet. 2011 Sep 17;378(9796):1079-88
pubmed: 21831418
J Clin Oncol. 2000 May;18(10):2095-103
pubmed: 10811675
Lung Cancer. 2021 Jan;151:20-24
pubmed: 33279874
J Clin Oncol. 2012 Jun 10;30(17):2055-62
pubmed: 22547591
Lancet Oncol. 2018 Jan;19(1):139-148
pubmed: 29174310
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Lancet Oncol. 2017 Dec;18(12):1590-1599
pubmed: 29074098
J Clin Oncol. 2008 Jul 20;26(21):3543-51
pubmed: 18506025
J Thorac Oncol. 2009 Jul;4(7):869-74
pubmed: 19487960
Lancet Oncol. 2014 Oct;15(11):1236-44
pubmed: 25175099
JAMA Oncol. 2016 Mar;2(3):305-12
pubmed: 26720423
Lancet Respir Med. 2017 May;5(5):435-444
pubmed: 28408243
Clin Cancer Res. 2018 Jun 15;24(12):2771-2779
pubmed: 29563138
J Clin Oncol. 2008 Nov 1;26(31):5043-51
pubmed: 18809614
J Natl Cancer Inst. 2007 Mar 21;99(6):442-50
pubmed: 17374834
JAMA Oncol. 2018 Jan 11;4(1):e173501
pubmed: 28973074
J Natl Cancer Inst. 2017 Jun 1;109(6):
pubmed: 28376144
N Engl J Med. 2013 Jun 20;368(25):2385-94
pubmed: 23724913
J Clin Oncol. 2015 Sep 1;33(25):2727-34
pubmed: 26101240
J Clin Oncol. 2010 May 1;28(13):2181-90
pubmed: 20351327
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Lancet Oncol. 2014 Feb;15(2):143-55
pubmed: 24411639
Clin Lung Cancer. 2017 Nov;18(6):595-606
pubmed: 28377206
Lancet Oncol. 2016 Jul;17(7):984-993
pubmed: 27283860
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
Lancet Oncol. 2016 Dec;17(12):1672-1682
pubmed: 27789196
Lancet. 2009 Oct 24;374(9699):1432-40
pubmed: 19767093
Ann Oncol. 2017 Feb 1;28(2):270-277
pubmed: 28426106
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006157
pubmed: 17636828
Lancet Oncol. 2017 Oct;18(10):1307-1316
pubmed: 28919011
Lancet Oncol. 2017 Jul;18(7):874-886
pubmed: 28602779
Lancet Oncol. 2015 Feb;16(2):141-51
pubmed: 25589191
Ann Oncol. 2018 Apr 1;29(4):953-958
pubmed: 29351573
Lancet Oncol. 2014 Oct;15(11):1254-62
pubmed: 25232001
J Clin Oncol. 2008 Oct 1;26(28):4617-25
pubmed: 18678835
J Clin Oncol. 2004 May 1;22(9):1589-97
pubmed: 15117980
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Lancet Oncol. 2015 Feb;16(2):187-99
pubmed: 25601342
Ann Oncol. 2014 Feb;25(2):415-22
pubmed: 24478318
J Mol Diagn. 2018 Mar;20(2):129-159
pubmed: 29398453

Auteurs

M Majem (M)

Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Sant Antoni Maria Claret 167, 08025, Barcelona, Spain. mmajem@santpau.cat.

O Juan (O)

Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

A Insa (A)

Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.

N Reguart (N)

Medical Oncology Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.

J M Trigo (JM)

Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

E Carcereny (E)

Medical Oncology Department, Institut Català d'Oncologia Badalona-Hospital Germans Trias i Pujol, Badalona, Spain.

R García-Campelo (R)

Medical Oncology Department, Complexo Hospitalario Universitario A Coruña, Coruña, Spain.

Y García (Y)

Medical Oncology Department, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Parc Taulí Hospital Universitari, Sabadell, Spain.

M Guirado (M)

Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain.

M Provencio (M)

Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH